312 related articles for article (PubMed ID: 25793613)
21. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study.
Mohamed AA; Elmotaleb Hussein MA; Nabil Hanna I; Japer Nashwan AJ; Saleh M; Abdel Wahed WY; Mohamed Mansour AM; Ezz Al Arab MR; Fawzy N; Sakr Y; Shalby H; AlHussain E; Kamal Darwish M; El-Osaily H; Naguib M; Mohamed AA; Farouk Mohamed W; Hafez W
Med Clin (Barc); 2024 May; 162(9):e33-e39. PubMed ID: 38458959
[TBL] [Abstract][Full Text] [Related]
22. Association of hsCRP and vitamin D levels with mild cognitive impairment in elderly type 2 diabetic patients.
Gorska-Ciebiada M; Ciebiada M
Exp Gerontol; 2020 Jul; 135():110926. PubMed ID: 32194146
[TBL] [Abstract][Full Text] [Related]
23. [Association between periodontitis and mild cognitive impairment: a clinical pilot study].
Lin ZK; Ma SJ; Qian JL; Lin SH; Xia YR; Xie YF; Wang HY; Shu R
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Jun; 57(6):576-584. PubMed ID: 35692001
[No Abstract] [Full Text] [Related]
24. Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus.
He Q; Dong M; Pan Q; Wang X; Guo L
Minerva Endocrinol; 2019 Sep; 44(3):252-258. PubMed ID: 29687969
[TBL] [Abstract][Full Text] [Related]
25. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
26. Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
Zhang JB; Cong YN; Li ZG; Sun HR; Zhang JS; Wang PF; Wu QZ
Curr Alzheimer Res; 2017; 14(6):592-597. PubMed ID: 27915992
[TBL] [Abstract][Full Text] [Related]
27. Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.
Chakraborty A; Hegde S; Praharaj SK; Prabhu K; Patole C; Shetty AK; Mayya SS; Acharya RV; Hande HM; Prabhu MM; Upadhya D
Front Endocrinol (Lausanne); 2021; 12():798652. PubMed ID: 35035379
[TBL] [Abstract][Full Text] [Related]
28. Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment.
Chen G; Cai L; Chen B; Liang J; Lin F; Li L; Lin L; Yao J; Wen J; Huang H
Diabetes Care; 2011 Dec; 34(12):2586-90. PubMed ID: 22011410
[TBL] [Abstract][Full Text] [Related]
29. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis.
Kardeşler L; Buduneli N; Cetinkalp S; Kinane DF
J Periodontol; 2010 Jan; 81(1):24-33. PubMed ID: 20059414
[TBL] [Abstract][Full Text] [Related]
30. Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).
Camacho Á; Larsen B; McClelland RL; Morgan C; Criqui MH; Cushman M; Allison MA
J Affect Disord; 2014 Aug; 164():165-70. PubMed ID: 24856570
[TBL] [Abstract][Full Text] [Related]
31. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?
Bahceci M; Gokalp D; Bahceci S; Tuzcu A; Atmaca S; Arikan S
J Endocrinol Invest; 2007 Mar; 30(3):210-4. PubMed ID: 17505154
[TBL] [Abstract][Full Text] [Related]
32. NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure.
Naudé PJ; Mommersteeg PM; Gouweleeuw L; Eisel UL; Denollet J; Westerhuis LW; Schoemaker RG
World J Biol Psychiatry; 2015 Oct; 16(7):536-41. PubMed ID: 26212793
[TBL] [Abstract][Full Text] [Related]
33. Leptin, hsCRP, TNF-α and IL-6 levels from normal aging to dementia: Relationship with cognitive and functional status.
Magalhães CA; Ferreira CN; Loures CMG; Fraga VG; Chaves AC; Oliveira ACR; de Souza LC; Resende EPF; Carmona KC; Guimarães HC; Cintra MTG; Lanna IN; Zauli DAG; Bicalho MA; Carvalho MG; Sousa LP; Caramelli P; Gomes KB
J Clin Neurosci; 2018 Oct; 56():150-155. PubMed ID: 30150062
[TBL] [Abstract][Full Text] [Related]
34. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
36. Identification of inflammatory and vascular markers associated with mild cognitive impairment.
Shen XN; Lu Y; Tan CTY; Liu LY; Yu JT; Feng L; Larbi A
Aging (Albany NY); 2019 Apr; 11(8):2403-2419. PubMed ID: 31039131
[TBL] [Abstract][Full Text] [Related]
37. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.
Lu L; Pu LJ; Xu XW; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Lu AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Clin Biochem; 2007 Jul; 40(11):810-6. PubMed ID: 17499233
[TBL] [Abstract][Full Text] [Related]
38. Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Tian S; Han J; Huang R; Sun J; Cai R; Shen Y; Wang S
J Alzheimers Dis; 2017; 58(4):1163-1173. PubMed ID: 28550262
[TBL] [Abstract][Full Text] [Related]
39. Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients.
Goyal S; Sood A; Gautam I; Pradhan S; Mondal P; Singh G; Jaura RS; Singh TG; Sibia RS
Inflammopharmacology; 2022 Oct; 30(5):1843-1851. PubMed ID: 35974263
[TBL] [Abstract][Full Text] [Related]
40. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).
Duivis HE; Vogelzangs N; Kupper N; de Jonge P; Penninx BW
Psychoneuroendocrinology; 2013 Sep; 38(9):1573-85. PubMed ID: 23399050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
